Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ALG001
MIFTS: 39

Algoneurodystrophy

Categories: Neuronal diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Algoneurodystrophy

About this section

MalaCards integrated aliases for Algoneurodystrophy:

Name: Algoneurodystrophy 12 15 71 32
Reflex Sympathetic Dystrophy 71

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:14022
ICD9CM 34 733.7
ICD10 32 M89.0
UMLS 71 C0034931 C0205930
Sources

Summaries for Algoneurodystrophy

About this section
MalaCards based summary : Algoneurodystrophy, also known as reflex sympathetic dystrophy, is related to reflex sympathetic dystrophy and barre-lieou syndrome. An important gene associated with Algoneurodystrophy is LCAT (Lecithin-Cholesterol Acyltransferase), and among its related pathways/superpathways are Neuroscience and Folate Metabolism. The drugs Gabapentin and Triamcinolone have been mentioned in the context of this disorder. Affiliated tissues include bone, spinal cord and skin.

Wikipedia : 74 Complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy (RSD), describes an... more...

Sources

Related Diseases for Algoneurodystrophy

About this section

Diseases related to Algoneurodystrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 105)
# Related Disease Score Top Affiliating Genes
1 reflex sympathetic dystrophy 31.2 TAC1 NPS CALCA
2 barre-lieou syndrome 10.4 PPT1 CALCA
3 bile duct rhabdomyosarcoma 10.2 GGTLC3 GGT2 GGT1
4 splenic tuberculosis 10.2 GGTLC3 GGT2 GGT1
5 perforation of bile duct 10.2 GGTLC3 GGT2 GGT1
6 gallbladder papillary carcinoma 10.2 GGTLC3 GGT2 GGT1
7 immature teratoma of ovary 10.2 GGTLC3 GGT2 GGT1
8 optic nerve astrocytoma 10.2 GGTLC3 GGT2 GGT1
9 myasthenic syndrome, congenital, 3b, fast-channel 10.2 GGTLC3 GGT2 GGT1
10 suppurative cholangitis 10.2 GGTLC3 GGT2 GGT1
11 dientamoebiasis 10.2 GGTLC3 GGT2 GGT1
12 bile duct cysts 10.2 GGTLC3 GGT2 GGT1
13 glutathionuria 10.2 GGTLC3 GGT2 GGT1
14 bile acid synthesis defect, congenital, 1 10.2 GGTLC3 GGT2 GGT1
15 common bile duct disease 10.2 GGTLC3 GGT2 GGT1
16 bile duct disease 10.2 GGTLC3 GGT2 GGT1
17 noonan syndrome 8 10.2 GGTLC3 GGT2 GGT1
18 amelogenesis imperfecta, type if 10.2 GGTLC3 GGT2 GGT1
19 familial adenomatous polyposis 2 10.2 GGTLC3 GGT2 GGT1
20 giant axonal neuropathy 1, autosomal recessive 10.2 GGTLC3 GGT2 GGT1
21 esophageal varix 10.2 GGTLC3 GGT2 GGT1
22 carpal tunnel syndrome 10.2
23 raynaud disease 10.2
24 osteomalacia 10.2
25 herpes zoster 10.2
26 raynaud phenomenon 10.2
27 cataract 34, multiple types 10.2 GGTLC3 GGT2 GGT1
28 choledocholithiasis 10.2 GGTLC3 GGT2 GGT1
29 loeys-dietz syndrome 2 10.2 GGTLC3 GGT2 GGT1
30 loeys-dietz syndrome 10.2 GGTLC3 GGT2 GGT1
31 cataract 4, multiple types 10.2 GGTLC3 GGT2 GGT1
32 contractural arachnodactyly, congenital 10.2 GGTLC3 GGT2 GGT1
33 hepatic vascular disease 10.2 GGTLC3 GGT2 GGT1
34 cholestasis, progressive familial intrahepatic, 1 10.1 GGTLC3 GGT2 GGT1
35 bilirubin metabolic disorder 10.1 GGTLC3 GGT2 GGT1
36 prurigo nodularis 10.1 TAC1 NGF
37 cholangitis, primary sclerosing 10.1 GGTLC3 GGT2 GGT1
38 biliary tract disease 10.1 GGTLC3 GGT2 GGT1
39 punctate epithelial keratoconjunctivitis 10.1 TAC1 NGF
40 alcohol use disorder 10.1 GGTLC3 GGT2 GGT1
41 cough variant asthma 10.1 TAC1 NGF
42 barbiturate dependence 10.1 DBH APEH
43 acute cholangitis 10.1 GGTLC3 GGT2 GGT1 CALCA
44 detrusor sphincter dyssynergia 10.0 TAC1 NGF CALCA
45 low compliance bladder 10.0 NPS NGF
46 burning mouth syndrome 10.0 TAC1 NGF CALCA
47 persian gulf syndrome 10.0 WARS1 NPS
48 corneal disease 10.0 TAC1 NGF LCAT
49 sensory peripheral neuropathy 10.0 TAC1 NGF CALCA
50 neurodermatitis 9.9 TAC1 NPS

Comorbidity relations with Algoneurodystrophy via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Algoneurodystrophy:



Diseases related to Algoneurodystrophy
Sources

Symptoms & Phenotypes for Algoneurodystrophy

About this section
Sources

Drugs & Therapeutics for Algoneurodystrophy

About this section

Drugs for Algoneurodystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 112)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
2
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
3
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
4
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
5 Micronutrients Phase 4
6 Trace Elements Phase 4
7 Vitamins Phase 4
8 Antioxidants Phase 4
9 Nutrients Phase 4
10 Anticonvulsants Phase 4
11 Excitatory Amino Acid Antagonists Phase 4
12 Anti-Anxiety Agents Phase 4
13 Psychotropic Drugs Phase 4
14 Neurotransmitter Agents Phase 4
15 triamcinolone acetonide Phase 4
16 Triamcinolone hexacetonide Phase 4
17 Triamcinolone diacetate Phase 4
18
Zoledronic Acid Approved Phase 3 118072-93-8 68740
19
Levobupivacaine Approved, Investigational Phase 3 27262-47-1 92253
20
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
21
Nitrous oxide Approved, Vet_approved Phase 3 10024-97-2 948
22
Imidacloprid Vet_approved Phase 3 105827-78-9 86418
23 Immunologic Factors Phase 3
24 Diphosphonates Phase 3
25 Antibodies Phase 3
26 Rho(D) Immune Globulin Phase 3
27 Immunoglobulins, Intravenous Phase 3
28 gamma-Globulins Phase 3
29 Immunoglobulins Phase 3
30 Narcotics Phase 3
31 Analgesics, Opioid Phase 3
32 Anesthetics, Intravenous Phase 3
33 Analgesics Phase 3
34 Analgesics, Non-Narcotic Phase 3
35 Anesthetics Phase 3
36 Anesthetics, General Phase 3
37 Anesthetics, Inhalation Phase 3
38
Dronabinol Approved, Illicit Phase 2 1972-08-3 16078
39
Cetuximab Approved Phase 2 205923-56-4 56842117 2333
40
Pregabalin Approved, Investigational Phase 2 148553-50-8 5486971
41
Clonidine Approved Phase 2 4205-90-7 2803
42
Amitriptyline Approved Phase 2 50-48-6 2160
43
Perphenazine Approved Phase 2 58-39-9 4748
44
Midazolam Approved, Illicit Phase 2 59467-70-8 4192
45
Nimodipine Approved, Investigational Phase 2 66085-59-4 4497
46
Lenalidomide Approved Phase 2 191732-72-6 216326
47
Ethosuximide Approved Phase 2 77-67-8 3291
48
Ketamine Approved, Vet_approved Phase 2 6740-88-1 3821
49 Hormone Antagonists Phase 2
50 Hallucinogens Phase 2

Interventional clinical trials:

(show top 50) (show all 120)
# Name Status NCT ID Phase Drugs
1 Restore Claims Characterization Study Completed NCT00200122 Phase 4
2 Prophylactic Administration of Vitamin C in Wrist Fractures; a Randomized Placebo Controlled Multicentre Dose-Finding Study of the Incidence of Complex Regional Pain Syndrome Completed NCT00296868 Phase 4 ascorbic acid (vitamin C) versus placebo
3 Assessing the Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome - a Feasibility Study Completed NCT03291197 Phase 4 Suprascapular and median nerve blocks
4 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
5 Single Blinded, Randomized Control Trial of High Frequency Stimulation in Subjects With Precision® Spinal Cord Stimulator System to Assess Efficacy and Preferability in Back and Extremity Pain Relief Completed NCT02265848 Phase 4
6 Randomized Clinical Trial of Exparel vs Pain Pump for Post-operative Pain Control After Total Shoulder Arthroplasty Not yet recruiting NCT04364867 Phase 4 Exparel;Pain Pump
7 Acupuncture and Traditional Chinese Medicine Combined With Rehabilitation Therapy for Post-stroke Shoulder-hand Syndrome in Community Hospital: a Multicenter，Randomized，Controlled Trial Unknown status NCT02011854 Phase 2, Phase 3
8 CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I) Unknown status NCT02504008 Phase 3 AXS-02 (oral zoledronate);Placebo
9 An Analysis of Photoplethysmographic Signal in Diagnostic Lumbar Sympathetic Block for Complex Regional Pain Syndrome Unknown status NCT01134289 Phase 3
10 Surgical Treatment of Complex Regional Pain Syndrome Type II (CRPS II) by Regional Subcutaneous Venous Sympathectomy Unknown status NCT01392599 Phase 3
11 Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery Unknown status NCT02390505 Phase 3 Vitamin C;Placebo
12 Double-Blind Randomized Controlled Trial: Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb Unknown status NCT01612364 Phase 3
13 Prospective, Double-blind, Randomised, Placebo-controlled, Cross-over Study to Investigate the Effect of Intravenous Immunoglobulins on Complex Regional Pain Syndrome (CRPS, M. Sudeck) Unknown status NCT00949065 Phase 3
14 Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1 Completed NCT00166452 Phase 3 Lenalidamide
15 Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS) Completed NCT02972359 Phase 3 Neridronic acid
16 A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I) Completed NCT02402530 Phase 2, Phase 3 Placebo;Neridronic acid 62.5 mg
17 A Verification Study of JNS020QD in Patients With Post-herpetic Neuralgia, Complex Regional Pain Syndrome (CRPS) or Postoperative Pain Syndrome Completed NCT01008553 Phase 3 Fentanyl;Placebo
18 Pain Exposure Physical Therapy Or Conservative Therapy for Patients With Complex Regional Pain Syndrome Type I Completed NCT00817128 Phase 2, Phase 3
19 The Effectiveness of Taping Technique Versus Conventional Techniques in Prevention of Shoulder Injuries in Patients With Acute Stroke-A Prospective, Randomized, Interventional, Outcome Blinded (PROBE Design), Parallel Design Trial Completed NCT01062308 Phase 3
20 A Prospective Randomized Controlled Pilot Study Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome Enrolling by invitation NCT03879538 Phase 3 Nitrous Oxide;Oxygen
21 Placebo-controlled Efficacy and Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS) Terminated NCT03560986 Phase 3 Neridronic acid;Placebo
22 Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS) Terminated NCT03530345 Phase 3 Neridronic acid;Placebo
23 Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception Withdrawn NCT00349050 Phase 2, Phase 3
24 Low Dose Administration of Delta9-Tetrahydrocannabinol for the Prevention of Hyperalgesia and Chronic Pain in Patients With Acute Complex Regional Pain Syndrome (CRPS) of the Upper Limb Unknown status NCT00377468 Phase 2 Delta9-Tetrahydrocannabinol
25 Phase 2 Study - The Use of a Single 5 mg Dose of Zoledronic Acid in Complex Regional Pain Syndrome Patient. Unknown status NCT01788176 Phase 2 Zoledronic acid;Placebo
26 Treatment Of Chronic Pain Using Real-time Functional MRI Trial Unknown status NCT00528346 Phase 2
27 A Multicenter, Open-Label Study to Evaluate the Preliminary Safety and Efficacy of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) Completed NCT00067743 Phase 2 Lenalidomide
28 A Randomized, Cross-over, Placebo-controlled, Double-blind, Single-center, Phase II Study of Cetuximab in Patients With Treatment-refractory, Non-malignant Severe Chronic Neuropathic Pain Completed NCT02490436 Phase 2 Cetuximab;Placebo
29 CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain Completed NCT01037088 Phase 1, Phase 2 Mild dose cannabis;Low dose cannabis;Cannabis
30 A Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset Complex Regional Pain Syndrome After Total Knee Arthroplasty Completed NCT00558753 Phase 2 pregabalin;Placebo
31 Comparative Study Between Amitriptyline Regarding Nimesulide Associated to Nervous Blockade in the Acute Treatment of Idiopathic Adhesive Capsulitis Completed NCT01306708 Phase 2 amitriptyline
32 Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS Completed NCT00579085 Phase 2 Ketamine
33 A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Adult Subjects With Chronic Complex Regional Pain Syndrome Active, not recruiting NCT03990649 Phase 2 TAK-935;TAK-935 Placebo
34 Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Reflex Sympathetic Dystrophy (RSD), Complex Regional Pain Syndrome (CRPS), and Fibromyalgia Enrolling by invitation NCT02987855 Phase 1, Phase 2
35 Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker in Prevention of Cerebrovascular Spasm in Traumatic Subarachnoid Hemorrhage Not yet recruiting NCT04100824 Phase 2 Nimodipine
36 A Single Centre. Parallel-Group, Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial on Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated NCT00689585 Phase 2 Placebo;Ethosuximide
37 Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain Terminated NCT00006289 Phase 2 Placebo;Neurotropin
38 A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 Terminated NCT00109772 Phase 2 lenalidomide;Placebo
39 Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome Terminated NCT02094352 Phase 2 Ketamine Infusion + Epidural Infusion;Control Group + Epidural infusion;Ketamine Booster Infusion;Control Group Booster Infusion
40 Prospective Single-Arm Pilot Study for CT-Guided, Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility Recruiting NCT04121338 Phase 1 Liposomal bupivacaine
41 Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. Terminated NCT02321566 Phase 1
42 The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture, Prospective Double Blind Study Unknown status NCT01338129 placebo
43 Comparison of Two Measures of Tactile Acuity in CRPS Type I Patients , Patients With a Neuropathy of the Median Nerve and Healthy Controls. Unknown status NCT01888783
44 Comparison of Gait Parameters Between Floor and Sponge Surfaces and Special Shoes in Individuals With Difficulties in Weight-bearing Unknown status NCT02742376
45 Effects of Repetitive Electric Sensory Stimulation on Sensorimotor Performance and Pain Intensity in Complex Regional Pain Syndrome Type I Unknown status NCT01915329
46 Effects of Proprioceptive Stimulation Under Visual Feedback in Patient With CRPS: An Exploratory Study Unknown status NCT02395211
47 Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial Unknown status NCT01118715
48 Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block: A Prospective Randomized Open-label Trial Unknown status NCT02737527 10 ml of 0.25% levobupivacaine injection for LSB
49 Capsaicin-Evoked Pain in Patients With Complex Regional Pain Syndrome Completed NCT00468390
50 TMS for CRPS - Pilot Study Completed NCT01926119

Search NIH Clinical Center for Algoneurodystrophy

Sources

Genetic Tests for Algoneurodystrophy

About this section
Sources

Anatomical Context for Algoneurodystrophy

About this section

MalaCards organs/tissues related to Algoneurodystrophy:

40
Bone, Spinal Cord, Skin, Testes, Cortex, Dorsal Root Ganglion, Brain
Sources

Publications for Algoneurodystrophy

About this section

Articles related to Algoneurodystrophy:

(show top 50) (show all 1677)
# Title Authors PMID Year
1
[Zheng's massage combined with electroacupuncture in the treatment of reflex sympathetic dystrophy syndrome of the wrist]. 61
32573159 2020
2
Outcome after the surgical treatment of the Dubberley type B distal humeral capitellar and trochlear fractures with a buttress plate. 61
32554364 2020
3
The role of trauma mechanism, fracture pattern and fixation technique on clinical outcomes and epiphyseal growth arrest in the surgical treatment of distal tibial epiphysiolysis. 61
32436969 2020
4
Economic evaluations of physiotherapy interventions for neurological disorders: a systematic review. 61
30616401 2020
5
A Paradigm Shift in Managing Acute and Chronic Boutonniere Deformity: Anatomic Rationale and Early Clinical Results for the Relative Motion Concept Permitting Immediate Active Motion and Hand Use. 61
32028337 2020
6
Cervicogenic exophthalmos: Possible etiology and pathogenesis. 61
32047780 2020
7
Peripheral Neuropathic Pain and Pain Related to Complex Regional Pain Syndrome with and without Fixed Dystonia - Efficient Therapeutic Approach with Local Anesthetics. 61
32099453 2020
8
[Calcitonin as an analgesic agent: review of mechanisms of action and clinical applications]. 61
31810524 2019
9
The application of dual-energy computed tomography in the diagnosis of musculoskeletal disorders: a review of current concepts and applications. 61
30828774 2019
10
Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. 61
31356731 2019
11
Reflex Sympathetic Dystrophy of the Right Hand following an Acute Traumatic Injury. 61
31608198 2019
12
Electroacupuncture for Reflex Sympathetic Dystrophy after Stroke: A Meta-Analysis. 61
30826129 2019
13
Ozone Therapy for Complex Regional Pain Syndrome: Review and Case Report. 61
31062104 2019
14
Complex regional pain syndrome - False hopes and miscommunications. 61
30639650 2019
15
[Mid-term results in the treatment of osteochondritis dissecans of the femoral condyles using osteochondral grafting (mosaic arthroplasty)]. 61
31312303 2019
16
Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey. 61
29775955 2018
17
Approach to the Patient with Disproportionate Pain. 61
29799372 2018
18
Complex Regional Pain Syndrome: What the Dermatologist Should Know. 61
29742184 2018
19
Mini-plate fixation via sinus tarsi approach is superior to cannulated screw in intra-articular calcaneal fractures: A prospective randomized study. 61
30101667 2018
20
How a Simple Ankle Sprain Turned Into Neuropathic Pain: Complex Reflex Sympathetic Dystrophy Versus Erythromelalgia. 61
29121832 2018
21
Living With Chronic Pain. 61
29669658 2018
22
Operative versus nonoperative treatment of displaced intra-articular calcaneal fractures: A meta-analysis of current evidence base. 61
29245290 2017
23
[Reflex sympathetic dystrophy involving the ankle and the foot in a particular pathological pregnancy: Exceptional association]. 61
28919273 2017
24
Outcomes Following Isolated Posterior Interosseous Nerve Neurectomy: A Systematic Review. 61
28720049 2017
25
Bone SPECT/CT Localizes Increased Bone Metabolism and Subsequent Bone Resorption in Reflex Sympathetic Dystrophy. 61
28806248 2017
26
Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture: A systematic review and meta-analysis. 61
28274883 2017
27
A Comprehensive Outcome-Specific Review of the Use of Spinal Cord Stimulation for Complex Regional Pain Syndrome. 61
27739179 2017
28
Quantitative determination of methamphetamine in oral fluid by liquid-liquid extraction and gas chromatography/mass spectrometry. 61
27022165 2017
29
The Unexpected Hand Patient. 61
28536645 2017
30
[Spinal cord stimulation in 62 patients: Retrospective evaluation]. 61
28467566 2017
31
Calcineurin Inhibitor-Induced Pain Syndrome in ABO-Incompatible Living Kidney Transplantation: A Case Report. 61
28104127 2017
32
[How I treat? complex regional pain syndrome]. 61
28387091 2016
33
Putative Physiopathological Explanation for the "Sock Sign" in Bone Scans. 61
27187731 2016
34
Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange. 61
26011726 2016
35
Late Spontaneous Migration of a Dorsal Column Stimulator Paddle Lead. 61
27672531 2016
36
Successful Treatment of Complex Regional Pain Syndrome with Pseudoaneurysm Excision and Median Nerve Neurolysis. 61
27318309 2016
37
Tibiotalocalcaneal arthrodesis by using proximal humeral locking plate. 61
27519965 2016
38
Steroid atrophy scarring treated with fat grafting in a patient with complex regional pain syndrome: A case report. 61
26735938 2016
39
The Relation Between Reflex Sympathetic Dystrophy Syndrome and Trauma Severity in Patients With Distal Tibia Fracture. 61
27626009 2016
40
Imaging in Foot and Ankle Arthritis. 61
27336451 2016
41
Operative Versus Nonoperative Treatment of Displaced Intra-Articular Calcaneal Fractures: A Meta-Analysis of Randomized Controlled Trials. 61
26371619 2016
42
Intratendinous rupture of the supraspinatus: anatomical and functional results of 24 operative cases. 61
26521196 2016
43
Complications of Proximal Biceps Tenotomy and Tenodesis. 61
26614476 2016
44
Mania following ketamine abuse. 61
26869791 2016
45
Management of Urinary and Fecal Incontinence in Patients With Complex Regional Pain Syndrome. 61
26516817 2016
46
Complex regional pain syndrome type I following pacemaker implantation. 61
26995412 2015
47
Three-Phase 99mTc-MDP Bone Scintigraphy and SPECT/CT in Pediatric Pseudodystrophy. 61
26252332 2015
48
Two peg spade plate for distal radius fractures: A novel technique. 61
26538760 2015
49
Plate Fixation of Proximal Fifth Metatarsal Fracture. 61
26429606 2015
50
[COMPLEX REGIONAL PAIN SYNDROME]. 61
26749953 2015
Sources

Variations for Algoneurodystrophy

About this section
Sources

Expression for Algoneurodystrophy

About this section
Search GEO for disease gene expression data for Algoneurodystrophy.
Sources

Pathways for Algoneurodystrophy

About this section

Pathways related to Algoneurodystrophy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Neuroscience 4
11.99 PTGS1 NGF DBH CALCA
2
Folate Metabolism 1
Show member pathways
 11.59 PTGS1 INS GGT2 GGT1
3
Aflatoxin activation and detoxification 65
10.62 GGT2 GGT1
4
Eicosanoid Synthesis 1
10.18 PTGS1 GGT2 GGT1
Sources

GO Terms for Algoneurodystrophy

About this section

Cellular components related to Algoneurodystrophy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 WARS1 PTGS1 PPT1 LCAT GGTLC3 GGT2
2 axon GO:0030424 9.62 TAC1 PPT1 NGF CALCA
3 extracellular space GO:0005615 9.56 TAC1 PPT1 NGF LCAT INS GGT1
4 extracellular region GO:0005576 9.28 TAC1 PPT1 NPS NGF LCAT INS
5 endosome lumen GO:0031904 9.26 NGF INS

Biological processes related to Algoneurodystrophy according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 neuropeptide signaling pathway GO:0007218 9.65 TAC1 NPS CALCA
2 regulation of blood pressure GO:0008217 9.58 TAC1 PTGS1 CALCA
3 positive regulation of blood vessel diameter GO:0097755 9.51 INS CALCA
4 zymogen activation GO:0031638 9.49 GGT2 GGT1
5 positive regulation of synaptic transmission, GABAergic GO:0032230 9.46 TAC1 NPS
6 regulation of immune system process GO:0002682 9.43 GGT2 GGT1
7 associative learning GO:0008306 9.43 TAC1 PPT1 DBH
8 positive regulation of action potential GO:0045760 9.37 TAC1 NPS
9 response to pain GO:0048265 9.33 TAC1 DBH CALCA
10 peptide modification GO:0031179 9.32 GGT2 GGT1
11 glutathione catabolic process GO:0006751 9.13 GGTLC3 GGT2 GGT1
12 leukotriene D4 biosynthetic process GO:1901750 8.8 GGTLC3 GGT2 GGT1

Molecular functions related to Algoneurodystrophy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidyltransferase activity GO:0000048 8.96 GGT2 GGT1
2 glutathione hydrolase activity GO:0036374 8.8 GGTLC3 GGT2 GGT1
Sources

Sources for Algoneurodystrophy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....